title: Nanotechnology-based strategies for the diagnosis and treatment of intracranial neoplasms.
authors: Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA; Institute for the Neurosciences at the Brigham and Women's/Faulkner Hospital, Boston, Massachusetts, USA; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Broad Institute of MIT and Harvard, Boston, Massachusetts, USA.
authors: Peleg M
authors: PM
authors: Horowitz
authors: E Antonio
authors: EA
authors: Chiocca
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D005290:Ferric Compounds / Q000008:administration & dosage*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D019809:Streptavidin / Q000627:therapeutic use*
chemical_list: D000906:Antibodies; D018951:Antigens, CD20; D005290:Ferric Compounds; D011993:Recombinant Fusion Proteins; C000499:ferric oxide; D019809:Streptavidin
keywords: BBB; Blood−brain barrier; CD20; CNS; Cell targeting; Central nervous system; MRI; Magnetic resonance imaging; Nanomedicine; PCNSL; Theranostic